CDNA - CareDxAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $79.08 | Open | $81.19 |
| Volume | 405.9K | Market Cap | 3.904B |
| Yield | Last Dividend |
| Exclusive: New CareDX CEO Reg Seeto Talk... | 02/23/21 |
| Benzinga recently spoke with CareDx Inc (NASDAQ: CDNA ) CEO Reginald Seeto to discuss the diagnostics surveillance solution provider's business, finan... | |
| CareDx to Report Fourth Quarter and Full... | 02/12/21 |
| SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) ??? CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discov... | |
| CareDx Announces Proposed Public Offerin... | 01/19/21 |
| SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discove... | |
| Sasha King Sells 9,875 Shares of CareDx,... | 01/17/21 |
| CareDx, Inc (NASDAQ:CDNA) insider Sasha King sold 9,875 shares of the stock in a transaction on Thursday, January 14th. The stock was sold at an avera... | |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| The Daily Biotech Pulse: GSK, Vir To Sta... | 01/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X... | |
| CareDx, Inc (NASDAQ:CDNA) Insider Sells ... | 01/08/21 |
| CareDx, Inc (NASDAQ:CDNA) insider Peter Maag sold 10,000 shares of the business???s stock in a transaction that occurred on Tuesday, January 5th. The ... | |
| The Zacks Analyst Blog Highlights: MACOM... | 12/31/20 |
| The Zacks Analyst Blog Highlights: MACOM Tech, CrowdStrike, Zscaler, CareDx and Medifast | |
| Zacks Industry Outlook Highlights: Apoll... | 12/18/20 |
| Zacks Industry Outlook Highlights: Apollo Medical, bioMerieux, CareDx and Harrow Health | |
| CareDx (CDNA) is a Great Momentum Stock:... | 12/14/20 |
| Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out. | |
| Raymond James Stick to Their Buy Rating ... | 12/10/20 |
| Raymond James Stick to Their Buy Rating for CareDx | |
| Global Circulating Tumor Cells (CTC) Liq... | 12/04/20 |
| Databridgemarketresearch.com added a new study on Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Review 2020 that has been just ma... | |
| CareDx (CDNA) Is Up 12.28% in One Week: ... | 11/26/20 |
| Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out. | |
| CareDx, Inc (NASDAQ:CDNA) Expected to Po... | 11/18/20 |
| Analysts forecast that CareDx, Inc (NASDAQ:CDNA) will announce earnings per share of ($0.02) for the current quarter, Zacks Investment Research report... | |
| New Publication Shows CareDx???s AlloSur... | 11/06/20 |
| Research from Johns Hopkins, University of Maryland, and Cedars Sinai Shows AlloSure May Signal BK Virus Progression in Transplant Patients SOUTH SAN?... | |
| CareDx Joins National Kidney Foundation ... | 11/06/20 |
| CareDx???s Chief Marketing Officer Sasha King is the Chair for the Upcoming Pacific Northwest Virtual Kidney Walk | |
| CareDx (CDNA) Beats Q3 Earnings and Reve... | 10/29/20 |
| CareDx (CDNA) delivered earnings and revenue surprises of 266.67% and 0.67%, respectively, for the quarter ended September 2020. Do the numbers hold c... | |
| CareDx, Inc.to Host Earnings Call | 10/29/20 |
| NEW YORK, NY / ACCESSWIRE / October 29, 2020 / CareDx, Inc. | |
| CareDx Earnings Scorecard & Analyst Repo... | 10/29/20 |
| CareDx announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| CareDx (CDNA) Scheduled to Post Quarterl... | 10/21/20 |
| CareDx (NASDAQ:CDNA) will announce its earnings results after the market closes on Thursday, October 29th. Analysts expect the company to announce ear... | |
| Research Analysts??? Recent Ratings Upda... | 10/20/20 |
| CareDx (NASDAQ: CDNA) has recently received a number of price target changes and ratings updates: 10/14/2020 ??? CareDx was upgraded by analysts at Bi... | |
| Global Liquid Biopsy Market Report Cover... | 10/16/20 |
| A DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the industry a... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| CareDx Soars 15% As 3Q Revenue Outlook S... | 10/09/20 |
| Shares of CareDx soared 15.2% on Thursday after the company reported preliminary 3Q revenues that exceeded Wall Street???s estimates and marked signif... | |
| IBM, CareDx: 5 Top Stock Gainers for Thu... | 10/08/20 |
| CareDx, IBM, Alphatec Holdings, Dun & Bradstreet and DTE Energy are some of the top stock gainers for Thursday. | |
| The Daily Biotech Pulse: Gilead, Lilly C... | 10/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ... | |
| Global Liquid Biopsy Market Future Growt... | 10/08/20 |
| DBMR has added a new report titled Global Liquid Biopsy Market with analysis provides the insights which bring marketplace clearly into the focus and ... | |
| The Daily Biotech Pulse: Bristol-Myers S... | 10/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ... | |
| The Daily Biotech Pulse: Amag Spikes On ... | 10/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Ac... | |
| Transplant Diagnostics Market With Curre... | 09/29/20 |
| The Business Research Company offers " Transplant Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. ... | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | $0.02/ 55.51M |
| Actual (EPS/Rev.) | $0.08/ $58.64 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
